270 related articles for article (PubMed ID: 27638339)
1. Deregulation of ocular nucleotide homeostasis in patients with diabetic retinopathy.
Loukovaara S; Sandholm J; Aalto K; Liukkonen J; Jalkanen S; Yegutkin GG
J Mol Med (Berl); 2017 Feb; 95(2):193-204. PubMed ID: 27638339
[TBL] [Abstract][Full Text] [Related]
2. Soluble and membrane-bound adenylate kinase and nucleotidases augment ATP-mediated inflammation in diabetic retinopathy eyes with vitreous hemorrhage.
Zeiner J; Loukovaara S; Losenkova K; Zuccarini M; Korhonen AM; Lehti K; Kauppinen A; Kaarniranta K; Müller CE; Jalkanen S; Yegutkin GG
J Mol Med (Berl); 2019 Mar; 97(3):341-354. PubMed ID: 30617853
[TBL] [Abstract][Full Text] [Related]
3. Increased intravitreal adenosine 5'-triphosphate, adenosine 5'-diphosphate and adenosine 5'-monophosphate levels in patients with proliferative diabetic retinopathy.
Loukovaara S; Sahanne S; Jalkanen S; Yegutkin GG
Acta Ophthalmol; 2015 Feb; 93(1):67-73. PubMed ID: 25079888
[TBL] [Abstract][Full Text] [Related]
4. Extracellular ATP formation on vascular endothelial cells is mediated by ecto-nucleotide kinase activities via phosphotransfer reactions.
Yegutkin GG; Henttinen T; Jalkanen S
FASEB J; 2001 Jan; 15(1):251-260. PubMed ID: 11149913
[TBL] [Abstract][Full Text] [Related]
5. CD73 controls ocular adenosine levels and protects retina from light-induced phototoxicity.
Losenkova K; Takeda A; Ragauskas S; Cerrada-Gimenez M; Vähätupa M; Kaja S; Paul ML; Schmies CC; Rolshoven G; Müller CE; Sandholm J; Jalkanen S; Kalesnykas G; Yegutkin GG
Cell Mol Life Sci; 2022 Feb; 79(3):152. PubMed ID: 35212809
[TBL] [Abstract][Full Text] [Related]
6. Ang-2 upregulation correlates with increased levels of MMP-9, VEGF, EPO and TGFβ1 in diabetic eyes undergoing vitrectomy.
Loukovaara S; Robciuc A; Holopainen JM; Lehti K; Pessi T; Liinamaa J; Kukkonen KT; Jauhiainen M; Koli K; Keski-Oja J; Immonen I
Acta Ophthalmol; 2013 Sep; 91(6):531-9. PubMed ID: 23106921
[TBL] [Abstract][Full Text] [Related]
7. Endothelial cells cope with hypoxia-induced depletion of ATP via activation of cellular purine turnover and phosphotransfer networks.
Losenkova K; Zuccarini M; Helenius M; Jacquemet G; Gerasimovskaya E; Tallgren C; Jalkanen S; Yegutkin GG
Biochim Biophys Acta Mol Basis Dis; 2018 May; 1864(5 Pt A):1804-1815. PubMed ID: 29514048
[TBL] [Abstract][Full Text] [Related]
8. Enzymes involved in metabolism of extracellular nucleotides and nucleosides: functional implications and measurement of activities.
Yegutkin GG
Crit Rev Biochem Mol Biol; 2014; 49(6):473-97. PubMed ID: 25418535
[TBL] [Abstract][Full Text] [Related]
9. Erythropoietin as a retinal angiogenic factor in proliferative diabetic retinopathy.
Watanabe D; Suzuma K; Matsui S; Kurimoto M; Kiryu J; Kita M; Suzuma I; Ohashi H; Ojima T; Murakami T; Kobayashi T; Masuda S; Nagao M; Yoshimura N; Takagi H
N Engl J Med; 2005 Aug; 353(8):782-92. PubMed ID: 16120858
[TBL] [Abstract][Full Text] [Related]
10. ATP-consuming and ATP-generating enzymes secreted by pancreas.
Yegutkin GG; Samburski SS; Jalkanen S; Novak I
J Biol Chem; 2006 Oct; 281(40):29441-7. PubMed ID: 16885159
[TBL] [Abstract][Full Text] [Related]
11. ATP release, generation and hydrolysis in exocrine pancreatic duct cells.
Kowal JM; Yegutkin GG; Novak I
Purinergic Signal; 2015 Dec; 11(4):533-50. PubMed ID: 26431833
[TBL] [Abstract][Full Text] [Related]
12. Imbalanced levels of angiogenic and angiostatic factors in vitreous, plasma and postmortem retinal tissue of patients with proliferative diabetic retinopathy.
Mohan N; Monickaraj F; Balasubramanyam M; Rema M; Mohan V
J Diabetes Complications; 2012; 26(5):435-41. PubMed ID: 22699109
[TBL] [Abstract][Full Text] [Related]
13. Adenosine metabolism in the vascular system.
Yegutkin GG
Biochem Pharmacol; 2021 May; 187():114373. PubMed ID: 33340515
[TBL] [Abstract][Full Text] [Related]
14. Correlation between ficolin-3 and vascular endothelial growth factor-to-pigment epithelium-derived factor ratio in the vitreous of eyes with proliferative diabetic retinopathy.
Zheng B; Li T; Chen H; Xu X; Zheng Z
Am J Ophthalmol; 2011 Dec; 152(6):1039-43. PubMed ID: 21851923
[TBL] [Abstract][Full Text] [Related]
15. Dinucleotide polyphosphates contribute to purinergic signalling via inhibition of adenylate kinase activity.
Yegutkin GG; Jankowski J; Jalkanen S; Günthner T; Zidek W; Jankowski V
Biosci Rep; 2008 Aug; 28(4):189-94. PubMed ID: 18576946
[TBL] [Abstract][Full Text] [Related]
16. Effect of intravitreal bevacizumab on serum, aqueous, and vitreous humor levels of erythropoietin in patients with proliferative diabetic retinopathy.
Cancarini A; Costagliola C; Dell'omo R; Romano M; Morescalchi F; Agnifili L; Ruggeri G; Semeraro F
Minerva Endocrinol; 2014 Dec; 39(4):305-11. PubMed ID: 25371057
[TBL] [Abstract][Full Text] [Related]
17. Soluble purine-converting enzymes circulate in human blood and regulate extracellular ATP level via counteracting pyrophosphatase and phosphotransfer reactions.
Yegutkin GG; Samburski SS; Jalkanen S
FASEB J; 2003 Jul; 17(10):1328-30. PubMed ID: 12759341
[TBL] [Abstract][Full Text] [Related]
18. The evidence for two opposite, ATP-generating and ATP-consuming, extracellular pathways on endothelial and lymphoid cells.
Yegutkin GG; Henttinen T; Samburski SS; Spychala J; Jalkanen S
Biochem J; 2002 Oct; 367(Pt 1):121-8. PubMed ID: 12099890
[TBL] [Abstract][Full Text] [Related]
19. Enzyme kinetics and pharmacological characterization of nucleotidases released from the guinea pig isolated vas deferens during nerve stimulation: evidence for a soluble ecto-nucleoside triphosphate diphosphohydrolase-like ATPase and a soluble ecto-5'-nucleotidase-like AMPase.
Mihaylova-Todorova ST; Todorov LD; Westfall DP
J Pharmacol Exp Ther; 2002 Sep; 302(3):992-1001. PubMed ID: 12183656
[TBL] [Abstract][Full Text] [Related]
20. Low intravitreal angiopoietin-2 and VEGF levels in vitrectomized diabetic patients with simvastatin treatment.
Tuuminen R; Sahanne S; Loukovaara S
Acta Ophthalmol; 2014 Nov; 92(7):675-81. PubMed ID: 24506800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
